Impact of Cytogenetics on Outcome of De novo and Therapy-related AML and MDS after Allogeneic Transplantation

Cytogenetics has an important impact on the prognosis of patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) for AML or MDS. However, it is unclear whether currently accepted cytogenetic risk groups, which were established for patients treated mostly with standard therapy,...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Armand, Philippe, Kim, Haesook T., DeAngelo, Daniel J., Ho, Vincent T., Cutler, Corey S., Stone, Richard M., Ritz, Jerome, Alyea, Edwin P., Antin, Joseph H., Soiffer, Robert J.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2007
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2743535/
https://ncbi.nlm.nih.gov/pubmed/17531775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2007.01.079
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים